These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2645177)
1. Clinical distribution of anticentromere antibody in Japanese patients. Soma Y; Takehara K; Ishibashi Y Dermatologica; 1989; 178(1):16-9. PubMed ID: 2645177 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of patients with anticentromere antibody. Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387 [TBL] [Abstract][Full Text] [Related]
6. Anticentromere and anticentriole antibodies in the scleroderma spectrum. Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899 [TBL] [Abstract][Full Text] [Related]
7. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease. Goldman JA Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800 [TBL] [Abstract][Full Text] [Related]
9. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma? Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618 [TBL] [Abstract][Full Text] [Related]
10. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants. McCarty GA; Rice JR; Bembe ML; Barada FA Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593 [TBL] [Abstract][Full Text] [Related]
11. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Fritzler MJ; Kinsella TD Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511 [TBL] [Abstract][Full Text] [Related]
13. The anticentromere antibody: disease specificity and clinical significance. Powell FC; Winkelmann RK; Venencie-Lemarchand F; Spurbeck JL; Schroeter AL Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675 [TBL] [Abstract][Full Text] [Related]
14. [The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions]. Sato S; Takehara K; Ishibashi Y Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):97-104. PubMed ID: 2072581 [TBL] [Abstract][Full Text] [Related]
15. The heterogeneity of anticentromere antibodies in immunoblotting analysis. Muro Y; Sugimoto K; Okazaki T; Ohashi M J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779 [TBL] [Abstract][Full Text] [Related]
18. Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Sarkozi J; Bookman AA; Lee P; Keystone EC; Fritzler MJ Am J Med; 1987 Nov; 83(5):893-8. PubMed ID: 3314499 [TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Kallenberg CG; Pastoor GW; Wouda AA; The TH Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989 [TBL] [Abstract][Full Text] [Related]
20. [Raynaud's phenomenon and anti-centromeric antibodies]. Marquet R; Villar MM; Ordi J; de la Figuera M; Vilardell M Med Clin (Barc); 1984 Jun; 83(3):129-30. PubMed ID: 6482556 [No Abstract] [Full Text] [Related] [Next] [New Search]